The emergence and prevalence of multidrug-resistant (MDR) bacteria have posed a serious
threat to public health. Of particular concern are methicillin-resistant Staphylococcus aureus …

Antimicrobial agents have eradicated many infectious diseases and significantly improved
our living environment. However, abuse of antimicrobial agents has accelerated the …

Abstract Objectives Though antimicrobial peptides (AMPs) show great potential as novel
antibiotics, therapeutic applications are hindered by their low stability, toxicity and high …

Pathogenic microorganisms are often associated with infectious diseases in humans, plants,
or animals. Over the past 100 years, antibiotics have been often used to combat the …

Multidrug-resistant (MDR) bacteria have emerged quickly and have caused serious
nosocomial infections. It is urgent to develop novel antimicrobial agents for treating MDR …

The recent upsurge of multidrug resistant bacteria (MDRB) among global communities has
become one of the most serious challenges facing health professionals and the human …

BMAP-27 and melittin are two antimicrobial peptides (AMPs) that display potent
antimicrobial activities against a wide range of microbes including multidrug resistant (MDR) …

With the aim of tackling the increasingly serious antimicrobial resistance and improving the
clinical potential of AMPs, a facile de novo strategy was adopted in this study, and a series of …

The prevalence of multidrug-resistant (MDR) pathogens raises public fears of untreatable
infections and represents a huge health risk. There is an urgent need to exploit novel …

Multidrug resistant (MDR) pathogen infections are serious threats to hospitalized patients
because of the limited therapeutic options. A novel group of antibiotic candidates …